Agarwal S, Mehta S. Food and drug administration gives breakthrough: sanctioning of Rezdiffra for non-alcoholic steatohepatitis. Int J Adv Med [Internet]. 2024 Dec. 23 [cited 2025 Apr. 18];12(1):155-. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/4152